MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

LH · NYSE

Labcorp Holdings Inc.

Health Care · Medical Specialities

Reference price$314.23As of Jul 28, 2026
Market capitalization$25.77B
52-week range$244.52–$301.79
S&P 500 portfolio weight0.04%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$290.00-7.7% vs. reference
Average$313.43-0.3% vs. reference
High$334.00+6.3% vs. reference
6 Buy1 Hold0 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportJul 30, 2026Jun 2026
Consensus EPS$4.797 estimates
Expected range$4.71–$5.02Low to high EPS
Dec 2026$18.00Street EPS consensus
Dec 2027$19.33Street EPS consensus
Dec 2028$20.71Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Dec 31, 2025.

MetricCurrentPrior
Revenue+7.2% YoY$13.95B$13.01B
Operating income$1.38B$1.09B
Net income$0.88B$0.75B
Operating cash flow$1.64B$1.59B
Capital expenditures($0.43B)($0.49B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

Zacks

Henry Schein Prepares to Report Q2 Earnings: What's in the Cards?

RTTNews

Biotech Stocks At 52-Week Highs - LH Rises With Genetic Testing Launch, DYN, SNDA, SLN, AMLX,

Zacks

Top Stock Reports for Bank of America, Netflix & TotalEnergies

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.